BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21658786)

  • 1. Can procalcitonin predict bone infection in people with diabetes with infected foot ulcers? A pilot study.
    Mutluoğlu M; Uzun G; İpcioğlu OM; Sildiroglu O; Özcan Ö; Turhan V; Mutlu H; Yildiz S
    Diabetes Res Clin Pract; 2011 Oct; 94(1):53-6. PubMed ID: 21658786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The performance of serum inflammatory markers for the diagnosis and follow-up of patients with osteomyelitis.
    Michail M; Jude E; Liaskos C; Karamagiolis S; Makrilakis K; Dimitroulis D; Michail O; Tentolouris N
    Int J Low Extrem Wounds; 2013 Jun; 12(2):94-9. PubMed ID: 23667102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current techniques to detect foot infection in the diabetic patient.
    Dinh T; Snyder G; Veves A
    Int J Low Extrem Wounds; 2010 Mar; 9(1):24-30. PubMed ID: 20207620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of procalcitonin, erythrocyte sedimentation rate (ESR), quantitative C-reactive protein (CRP) and clinical findings associated with osteomyelitis in patients with diabetic foot.
    Soleimani Z; Amighi F; Vakili Z; Momen-Heravi M; Moravveji SA
    Hum Antibodies; 2021; 29(2):115-121. PubMed ID: 33749641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study.
    Jeandrot A; Richard JL; Combescure C; Jourdan N; Finge S; Rodier M; Corbeau P; Sotto A; Lavigne JP
    Diabetologia; 2008 Feb; 51(2):347-52. PubMed ID: 17934713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of procalcitonin measurement in localized skin and skin structure infection, diabetic foot infections, septic arthritis and osteomyelitis.
    Saeed K; Ahmad N; Dryden M
    Expert Rev Mol Diagn; 2014 Jan; 14(1):47-54. PubMed ID: 24308337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does treatment affect the levels of serum interleukin-6, interleukin-8 and procalcitonin in diabetic foot infection? A pilot study.
    Altay FA; Sencan İ; Şentürk GÇ; Altay M; Güvenman S; Ünverdi S; Açıkgöz ZC
    J Diabetes Complications; 2012; 26(3):214-8. PubMed ID: 22521320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin as a diagnostic aid in diabetic foot infections.
    Uzun G; Solmazgul E; Curuksulu H; Turhan V; Ardic N; Top C; Yildiz S; Cimsit M
    Tohoku J Exp Med; 2007 Dec; 213(4):305-12. PubMed ID: 18075234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of procalcitonin as a marker of diabetic foot ulcer infection.
    Massara M; De Caridi G; Serra R; Barillà D; Cutrupi A; Volpe A; Cutrupi F; Alberti A; Volpe P
    Int Wound J; 2017 Feb; 14(1):31-34. PubMed ID: 26511007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of inflammatory markers to diagnose and monitor diabetic foot osteomyelitis.
    Van Asten SA; Nichols A; La Fontaine J; Bhavan K; Peters EJ; Lavery LA
    Int Wound J; 2017 Feb; 14(1):40-45. PubMed ID: 26634954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Inquiry: What's the best test for underlying osteomyelitis in patients with diabetic foot ulcers?
    Khodaee M; Lombardo D; Montgomery LC; Lyon C; Montoya C
    J Fam Pract; 2015 May; 64(5):309-10, 321. PubMed ID: 26009740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin as a diagnostic and prognostic marker in diabetic foot infection. A current literature review.
    Velissaris D; Pantzaris ND; Platanaki C; Antonopoulou N; Gogos C
    Rom J Intern Med; 2018 Mar; 56(1):3-8. PubMed ID: 29028632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of circulatory procalcitonin as a biomarker reflecting inflammation among South Indian diabetic foot ulcers.
    Umapathy D; Dornadula S; Rajagopalan A; Murthy N; Mariappanadar V; Kesavan R; Kunka Mohanram R
    J Vasc Surg; 2018 Apr; 67(4):1283-1291.e2. PubMed ID: 28736121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin is a specific marker for detecting bacterial infection in patients with rheumatoid arthritis.
    Sato H; Tanabe N; Murasawa A; Otaki Y; Sakai T; Sugaya T; Ito S; Otani H; Abe A; Ishikawa H; Nakazono K; Kuroda T; Nakano M; Narita I
    J Rheumatol; 2012 Aug; 39(8):1517-23. PubMed ID: 22753652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Biomarkers to Diagnose Diabetic Foot Osteomyelitis. A Meta-analysis.
    Victoria van Asten SA; Geradus Peters EJ; Xi Y; Lavery LA
    Curr Diabetes Rev; 2016; 12(4):396-402. PubMed ID: 26166314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are serum procalcitonin and interleukin-1 beta suitable markers for diagnosis of acute pyelonephritis in children?
    Mahyar A; Ayazi P; Ahmadi R; Daneshi-Kohan MM; Hashemi HJ; Dalirani R; Moshiri SA; Habibi M; Sahmani M; Sahmani AA
    Prague Med Rep; 2014; 115(1-2):16-23. PubMed ID: 24874931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of procalcitonin in infected diabetic foot ulcer.
    Park JH; Suh DH; Kim HJ; Lee YI; Kwak IH; Choi GW
    Diabetes Res Clin Pract; 2017 Jun; 128():51-57. PubMed ID: 28448892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin better than C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in predicting DNAemia in patients with sepsis.
    Leli C; Cardaccia A; Ferranti M; Cesarini A; D'Alò F; Ferri C; Cenci E; Mencacci A
    Scand J Infect Dis; 2014 Nov; 46(11):745-52. PubMed ID: 25195647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of inflammatory markers in diagnosing infected diabetic foot ulcers and diabetic foot osteomyelitis: Systematic review and meta-analysis.
    Sharma H; Sharma S; Krishnan A; Yuan D; Vangaveti VN; Malabu UH; Haleagrahara N
    PLoS One; 2022; 17(4):e0267412. PubMed ID: 35476639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacies of procalcitonin and conventional inflammatory markers for prediction of renal parenchymal inflammation in pediatric first urinary tract infection.
    Kotoula A; Gardikis S; Tsalkidis A; Mantadakis E; Zissimopoulos A; Deftereos S; Tripsianis G; Manolas K; Chatzimichael A; Vaos G
    Urology; 2009 Apr; 73(4):782-6. PubMed ID: 19152962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.